C4 Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. CCCC

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

37,721

Value ($000)

72

Weight

0.0%

2022 Q4 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	72	0.0%	37,721	12/31/2025
2024 Q1	5/9/2024	1,424	0.0%	174,356	3/31/2024
2023 Q4	2/9/2024	950	0.0%	168,218	12/31/2023
2023 Q3	11/13/2023	306	0.0%	164,722	9/30/2023
2023 Q2	8/10/2023	479	0.0%	174,359	6/30/2023
2023 Q1	5/10/2023	358	0.0%	113,893	3/31/2023
2022 Q4	2/10/2023	85	0.0%	14,457	12/31/2022